Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Clifton Robbins and Other Hedge Funds Are Bullish On This Manufacturer of Agricultural Equipment

Clifton S. Robbins is taking advantage of the recent market sell-off to buy AGCO Corporation (NYSE: AGCO) shares at a low. In a newly-amended filing with the Securities and Exchange Commission, Robbins’ fund, Blue Harbour Group, has disclosed an increase in its holding to approximately 6.52 million shares, up from 4.68 million shares reported in its latest 13F filing. As a result, Robbins now has control over 7.5% of the AGCO’s common stock, with the hedge fund industry having mixed sentiments towards the stock.

Clifton Robbins - Blue Harbour

An avid supporter of activist investing, Clifton Robbins stands out from the likes of Carl Icahn or Bill Ackman with his “friendly” approach to activism. He invests mainly in small- and mid-cap companies, whose management is open to collaboration, and has never engaged in a proxy contest or other aggressive tactics to increase his influence. Blue Harbour Group manages two funds: Blue Harbour Strategic Value Partners, a long/short fund, and the long-only Blue Harbour Active Ownership Partners. At the end of the second quarter, Blue Harbour reported an equity portfolio with a value of $3.42 billion, with 37% of the capital invested in technology stocks, while 25% were pledged to the industrial sector. AGCO Corporation (NYSE:AGCO), the subject of this article, is among the top five holdings of Clifton Robbins, who has increased his stake in the company by 23% during the second quarter. Rackspace Hosting, Inc. (NYSE:RAX) is still his top equity bet, with Blue Harbour holding 10.3 million shares at the end of June. Akamai Technologies, Inc. (NASDAQ:AKAM) is one stock Robbins decided to trim exposure to, cutting his stake by 10% to 4.93 million shares, while his investment in BWX Technologies Inc (NYSE:BWXT) has remained unchanged at 10.5 million shares as of June 30.

Clifton S. Robbins
Clifton S. Robbins
Blue Harbour Group

We don’t just track the latest moves of hedge funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research which showed that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests, and easily beating the most popular large-cap picks of funds, which nonetheless get the majority of their collective capital. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic only the very best ideas of the best fund managers on your own? Since the beginning of forward testing in August 2012, the Insider Monkey small-cap strategy has outperformed the market every year, returning 118%, nearly 2.1 times greater returns than the S&P 500 during the same period (see more details).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.